SBRT for Pancreas CA & Liver Mets

Stereotactic Body Radiotherapy for the Treatment of Locally Advanced Pancreatic Cancer and Colorectal Liver Metastasis

Presented at the SRS/SBRT Scientific Meeting 2014 by:

  • Joseph Herman, MD, MSc, Division Head ad interim and Professor and Director of Clinical Research, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
  • Albert C. Koong, MD, PhD, Professor and Department Chair, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
NOTE: At time of this presentation Dr. Herman was with Johns Hopkins University and Dr. Koong was at Stanford University.

This course is available from October 13, 2014, through 11:59 p.m. Eastern time on December 31, 2021.

In order to earn credit for this course, participants must:

    • View the audio/slide presentation
    • Pass the five-question examination with a minimum of 70 percent, and
    • Complete the course evaluation

The activity is approximately 1.5 hours in length.

Course Fees

  • Non-Member: $25.00
  • RSS Member: Free 
    • Login to find your discount code. It is on the member resources page.

Statement of Need

The use of stereotactic body radiotherapy (SBRT) for the treatment of pancreatic cancer and liver metastases is continuously evolving.  SBRT has been shown to be effective for the local control of locally advanced, unresectable pancreatic cancer in both the neo-adjuvant and adjuvant setting.  SBRT has also been shown to be effective for local control of liver metastases where the primary disease is under control or undergoing treatment.  There is a need to improve therapy for the local control of pancreatic cancer and liver metastasis and SBRT may be a viable treatment option for selective patients.  The optimal SBRT dose, fractionation regimens and integration with chemotherapy and biologic agents needs to be further defined to maximize the therapeutic benefits.

Target Audience

This program is designed to meet the needs of radiation oncologists and residents-in-training with interests in SBRT for the treatment of pancreatic tumors and colorectal liver metastases.

Activity Objectives

  • Explain the basic principles of SBRT and the rationale for the use of SBRT in the treatment of locally advanced pancreatic cancer and colorectal liver metastasis through evidence-based literature
  • Describe the patient selection for SBRT for the treatment of locally advanced pancreatic cancer and colorectal liver metastasis
  • Understand the role of imaging in treatment planning of SBRT and describe patient set-up for SBRT delivery
  • Discuss the principles of treatment planning to deliver SBRT to pancreatic and liver tumors
  • Understand the toxicities associated with SBRT treatment of pancreatic and liver lesions

Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Minnesota Medical Association and The Radiosurgery Society. The Minnesota Medical Association (MMA) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CME Statement

The Minnesota Medical Association designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This SAM has been qualified by the American Board of Radiology (ABR) in meeting the criteria for self-assessment toward the purpose of fulfilling requirements in the ABR Maintenance of Certification Program on August 27, 2014.

Certificate of Participation

A certificate will be issued upon completion of course requirements, including the evaluation, enabling you to register your credit with the appropriate licensing boards or associations.

Technology Requirements

Software Requirements

  • A browser version of Internet Explorer 10.0 and higher or Firefox 3.0 or higher, Google Chrome Version 35 or higher

A note on browser incompatibility:

  • We have tested IE 6.x in controlled configurations and we can stream successfully, but there are some versions that may not support the RTMP streams we push out - basically new technology that old technology can't handle.
  • Possible remedy: upgrade browser version, try alternate browsers such as Firefox.
  • Flash Player Version 11 or higher. If you have an older version it would be best to upgrade now. It's free and does not require a reboot.

Hardware Requirements

  • Windows Based Computer, Mac based Computers, smart phone, tablets
  • Windows XP SP 3 or Vista Home Premium or better
  • Mac OS x 10.5.3 or better
  • Pentium 4 or better
  • 1meg of System Ram (Memory)
  • True Color 32 bit video card
  • Sound card and speakers
For more help with technical issues please click here.


No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the course by the end of the qualification date. The qualification date for each course is listed on the RSS website under the title of the course.

Participants using RSS online courses to satisfy the requirement of a Maintenance of Certification (MOC) program should verify the number, type and availability dates of any course before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased courses that do not align with their MOC requirement.

The course and its materials will only be available on the RSS website for that 3 year period regardless of purchase date. At the expiration of the qualification, participants will no longer have access to the course or its materials. The RSS reserves the right to remove a course before the end of its qualification period.

Please contact if you have questions.

Member login  

Like our Facebook Page   
Join our Facebook Group
Follow us on Twitter 
Follow our Group on LinkedIn
Visit our Journal on Cureus

Journal of Neuro-Oncology
Join our Mailing List